1774P - Patient-reported outcomes associated with switching to rivaroxaban for the treatment of venous thromboembolism (VTE) in patients with active cancer

Autor: Cohen, A.T. 1, Maraveyas, A. 2, Beyer-Westendorf, J. 3, Lee, A.Y.Y. 4, Mantovani, L.G. 5, Folkerts, K. 6, Bach, M. 6, De Sanctis, Y. 7, Abdelgawad, K. 6
Zdroj: In Annals of Oncology October 2019 30 Supplement 5:v724-v725
Databáze: ScienceDirect